The CDKN2aIP and NL Polyclonal Antibody (PAC025688) is a valuable tool for researchers studying the CDKN2aIP and NL protein, which plays a role in cell cycle regulation and tumor suppression. This antibody, generated in rabbits, is highly specific to human samples and is validated for Western blot applications. By targeting the CDKN2aIP and NL protein, researchers can detect and analyze its expression in various cell types, making it ideal for investigations in cancer research and cell biology.
CDKN2aIP and NL, also known as CDKN2A-interacting protein and nucleolar like protein, is a key player in regulating cell proliferation and preventing abnormal cell growth. Its involvement in cell cycle control highlights its importance in understanding cancer development and progression. By studying the function of CDKN2aIP and NL, researchers can gain insights into potential therapeutic targets for cancer treatment and drug development.
Antibody Name:
CDKN2AIPNL Antibody (PACO25688)
Antibody SKU:
PACO25688
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, IHC
Recommended Dilutions:
ELISA:1:2000-1:10000, IHC:1:20-1:200
Species Reactivity:
Human
Immunogen:
Recombinant Human CDKN2AIP N-terminal-like protein (1-116AA)
Immunohistochemistry of paraffin-embedded mouse liver tissue using PACO25688 at dilution of 1:100.
Immunohistochemistry of paraffin-embedded human colon cancer using PACO25688 at dilution of 1:100.
Synonyms:
CDKN2AIP N-terminal-like protein (CDKN2A-interacting protein N-terminal-like protein), CDKN2AIPNL
UniProt Protein Function:
CDKN2AIPNL: Belongs to the CARF family. 2 isoforms of the human protein are produced by alternative splicing.Chromosomal Location of Human Ortholog: 5q31.1Cellular Component: nucleolus; nucleoplasmBiological Process: signal transduction
